Table 3.
Properties of SB and NG recorded in the Cg and PL of neonatal rats under control conditions (intracortical application of ACSF) and after blockade of mAChRs with intracortically applied atropine
| Properties | Discontinuous activity (P7–P8) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Cg |
PL |
|||||||
| SB |
NG |
SB |
NG |
|||||
| ACSF | Atropine | ACSF | Atropine | ACSF | Atropine | ACSF | Atropine | |
| Occurrence (bursts/min) | 1.5 ± 0.42 | 1.67 ± 0.3 | 0.3 ± 0.08 | 0.09 ± 0.06 | 1.72 ± 0.18 | 2 ± 0.13 | 0.42 ± 0.08 | 0.11 ± 0.04 |
| (p = 0.043)* | (p = 0.049)* | |||||||
| Duration (s) | 2.97 ± 0.28 | 2.63 ± 0.32 | 2.4 ± 0.27 | 1.04 ± 0.3 | 2.7 ± 0.16 | 2.29 ± 0.15 | 1.93 ± 0.16 | 1.62 ± 0.28 |
| (p = 0.028)* | (p = 0.049)* | |||||||
| Amplitude (μV) | 112.91 ± 17.49 | 139.88 ± 14.18 | 134.4 ± 16.84 | 188.97 ± 49.24 | 149.98 ± 13.31 | 145.59 ± 12.09 | 196.93 ± 27.5 | 249.99 ± 43.31 |
| Main frequency (Hz) | 7.4 ± 0.4 | 8.82 ± 0.83 | 8.46 ± 0.65 | 11.78 ± 1.56 | 7.08 ± 0.3 | 7.05 ± 0.32 | 6.55 ± 0.54 | 10.2 ± 2.98 |
| Relative power theta (%) | 34.98 ± 2.37 | 28.73 ± 2.51 | 27.65 ± 2.72 | 19.74 ± 6.98 | 39.32 ± 1.35 | 34.63 ± 1.41 | 39.12 ± 2.76 | 32.59 ± 5.86 |
| (p = 0.043)* | (p = 0.016)* | |||||||
| Relative power alpha (%) | 23.84 ± 1.43 | 18.5 ± 1.31 | 30.93 ± 2.46 | 16.16 ± 2.36 | 22.91 ± 1.02 | 22.18 ± 0.93 | 18.85 ± 1.54 | 18.46 ± 3.22 |
| (p = 0.012)* | (p = 0.018)* | |||||||
| Relative power beta (%) | 25.35 ± 1.87 | 36.02 ± 3.09 | 26.43 ± 1.92 | 42.88 ± 7 | 23.51 ± 1.21 | 28.8 ± 1.34 | 26.09 ± 2.14 | 27.72 ± 3.97 |
| (p = 0.005)** | (p = 0.003)** | |||||||
Values are presented as mean ± SEM, and significance values (*p < 0.05, **p < 0.01, ***p < 0.001, Mann–Whitney–Wilcoxon test) are indicated in parentheses.